This National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I project under CFDA 47.084 - NSF Technology, Innovation, and Partnerships provides $275,000 to Medfree Inc., a minority-owned small business, to develop a novel, transcatheter device and procedure for the minimally invasive surgical revision and repair of the tricuspid valve. The project aims to address the significant unmet need for percutaneous treatment options for the over 1.6 million U.S. patients suffering from moderate to severe tricuspid valve regurgitation, a market estimated to reach $2.4 billion by 2028. The Phase I objectives include demonstrating the ability to grasp valve leaflets, validating the device design using bench models, and performing preclinical testing of a transcatheter tricuspid edge-to-edge repair procedure via the jugular vein. The results from this technology development and testing will further the system towards eventual human clinical trials and commercialization.
Generated 8/13/24, 2:48 AM